Searched for
ZETIA SUN PHARMA
Nifty Pharma trading up, Sun Pharma top gainerAmong the 51 stocks in Nifty index, 37 were trading in green, while 14 were in red.
13 Jun, 2017, 09.55 AM IST
Sensex rises over 100 points; Nifty above 9,600; Sun Pharma, UltraTech top gainersAfter opening on a flat note, the BSE Sensex was trading 100 points up at 31,195.
13 Jun, 2017, 09.51 AM IST
Top stocks in focus on Tuesday, 13 June 2017US Fed’s meet will loom over the market while poor IIP numbers may kill feel-good factor.
13 Jun, 2017, 08.29 AM IST
Pricing pressure in US to keep pharma companies' growth under checkDr Reddy's Lab is expected to report subdued numbers in 3QFY17, with revenue declining 6.1 per cent Y-o-Y to Rs 37.2 billion and PAT down 2...
15 Jan, 2017, 04.20 PM IST
Fifteen stocks in focus on Tuesday, 13 December 2016Dairy firm Kwality on Monday reported a 12 per cent increase in its net profit at Rs 42.07 crore for the second quarter of this fiscal. The...
13 Dec, 2016, 08.26 AM IST
After Trump win, pharma is best sector to stick with: Hemang Jani, Sharekhan“We like Glenmark Pharma and Aurobindo because these two companies have extremely high approval rates”
10 Nov, 2016, 10.28 AM IST
USFDA nods to Indian drugs up 84% in 1 yearInterestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...
28 Jun, 2016, 09.47 AM IST
Indian companies get USFDA nod for 14 1st-time generic drugs in 2015Indian pharma firms accounted for 14 of total 90 first-time generic drug approvals granted by the United States Food and Drug Administratio...
15 Apr, 2016, 07.00 PM IST
Despite being on rough end, annual report from US FDA’s OGD shows Indian firms won key approvals in 2015The annual report released by the FDA’s OGD shows Indian companies have won some key approvals in the world’s biggest pharmaceuticals marke...
15 Apr, 2016, 01.41 AM IST
- Trileptal copy seen boosting Glenmark's US sales by $20 mn
India’s Glenmark Pharmaceuticals is likely to record sales of about $20 million in the United States for its generic version of Novartis’ e...
02 Nov, 2007, 04.39 AM IST